Financhill
Sell
32

TLK Quote, Financials, Valuation and Earnings

Last price:
$14.77
Seasonality move :
2.9%
Day range:
$14.54 - $14.85
52-week range:
$13.88 - $22.38
Dividend yield:
14.94%
P/E ratio:
10.24x
P/S ratio:
1.54x
P/B ratio:
1.63x
Volume:
545.4K
Avg. volume:
873.7K
1-year change:
-33.65%
Market cap:
$14.6B
Revenue:
$9.8B
EPS (TTM):
$1.44
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $9.6B $9.4B $10B $9.9B $9.8B
Revenue Growth (YoY) 4.12% -1.71% 5.95% -0.49% -1.33%
 
Cost of Revenues $3B $2.8B $3B $2.9B $3B
Gross Profit $6.6B $6.7B $7B $7B $6.8B
Gross Profit Margin 68.63% 70.7% 69.76% 70.39% 69.12%
 
R&D Expenses $3.2M $3.6M -- -- --
Selling, General & Admin $1.5B $1.5B $1.6B $1.6B $1.6B
Other Inc / (Exp) -$37.6M -$66.6M $237M -$422.3M -$51.4M
Operating Expenses $3.5B $3.6B $3.9B $3.9B $3.8B
Operating Income $3.1B $3B $3.1B $3.1B $3B
 
Net Interest Expenses $307.7M $262.2M $267.1M $215.5M $238.2M
EBT. Incl. Unusual Items $2.7B $2.7B $3B $2.5B $2.7B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $737.3M $638.4M $671.1M $586.7M $576.5M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -$621M -$609.6M -$642M -$470.4M -$501.3M
Net Income to Common Excl Extra Items $1.3B $1.5B $1.7B $1.4B $1.6B
 
Basic EPS (Cont. Ops) $1.36 $1.47 $1.75 $1.41 $1.62
Diluted EPS (Cont. Ops) $1.36 $1.47 $1.75 $1.41 $1.62
Weighted Average Basic Share $990.6M $990.6M $990.6M $990.6M $990.6M
Weighted Average Diluted Share $990.6M $990.6M $990.6M $990.6M $990.6M
 
EBITDA $5B $5B $5.6B $5B $5.1B
EBIT $3.1B $3B $3.4B $2.7B $3B
 
Revenue (Reported) $9.6B $9.4B $10B $9.9B $9.8B
Operating Income (Reported) $3.1B $3B $3.1B $3.1B $3B
Operating Income (Adjusted) $3.1B $3B $3.4B $2.7B $3B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $2.2B $2.5B $2.5B $2.5B $2.3B
Revenue Growth (YoY) -4.77% 13% -2.57% 0.49% -5.61%
 
Cost of Revenues $689.1M $752.7M $704.8M $730.6M $759M
Gross Profit $1.6B $1.8B $1.8B $1.7B $1.6B
Gross Profit Margin 69.25% 70.28% 71.44% 70.54% 67.57%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $351.4M $382.8M $409.7M $398.7M $378.5M
Other Inc / (Exp) $21.8M -$554.1K -$223.5M -$38.2M $11.3M
Operating Expenses $847.7M $901.4M $961.4M $925.1M $907.3M
Operating Income $704.4M $878.5M $801.3M $823.9M $674.3M
 
Net Interest Expenses $66.5M $83.7M $58.2M $64.7M $71.2M
EBT. Incl. Unusual Items $659.7M $794.2M $519.6M $721M $614.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $150.5M $188.6M $167.7M $158.4M $132.9M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -$123.8M -$160.8M -$133.1M -$119.8M -$106.7M
Net Income to Common Excl Extra Items $385.4M $444.8M $218.8M $442.8M $374.8M
 
Basic EPS (Cont. Ops) $0.39 $0.45 $0.22 $0.45 $0.38
Diluted EPS (Cont. Ops) $0.39 $0.45 $0.22 $0.45 $0.38
Weighted Average Basic Share $990.6M $990.6M $990.6M $990.6M $990.6M
Weighted Average Diluted Share $990.6M $990.6M $990.6M $990.6M $990.6M
 
EBITDA $1.2B $1.4B $1.1B $1.3B $1.2B
EBIT $737.1M $885.8M $590.2M $800.9M $705.6M
 
Revenue (Reported) $2.2B $2.5B $2.5B $2.5B $2.3B
Operating Income (Reported) $704.4M $878.5M $801.3M $823.9M $674.3M
Operating Income (Adjusted) $737.1M $885.8M $590.2M $800.9M $705.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $9.3B $9.8B $10B $9.8B $9.5B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $2.6B $2.9B $3B $3B $3B
Gross Profit $6.7B $7B $7B $6.8B $6.5B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1.4B $1.6B $1.7B $1.6B $1.7B
Other Inc / (Exp) -$32.6M -$34.9M $14.7M -$218.2M -$45.9M
Operating Expenses $3.8B $3.7B $4.1B $3.8B $3.8B
Operating Income $3B $3.3B $2.9B $3B $2.7B
 
Net Interest Expenses $338.9M $270.8M $225.4M $231.3M $238.2M
EBT. Incl. Unusual Items $2.6B $2.9B $2.7B $2.6B $2.4B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $652.9M $693.8M $578.1M $605.6M $536.9M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -$582.7M -$645.4M -$595.8M -$437.8M -$448.7M
Net Income to Common Excl Extra Items $1.3B $1.6B $1.6B $1.6B $1.4B
 
Basic EPS (Cont. Ops) $1.36 $1.62 $1.57 $1.57 $1.44
Diluted EPS (Cont. Ops) $1.36 $1.62 $1.57 $1.57 $1.44
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $5.1B $5.3B $5.4B $5B $4.8B
EBIT $3B $3.3B $3B $2.9B $2.7B
 
Revenue (Reported) $9.3B $9.8B $10B $9.8B $9.5B
Operating Income (Reported) $3B $3.3B $2.9B $3B $2.7B
Operating Income (Adjusted) $3B $3.3B $3B $2.9B $2.7B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $7.4B $7.4B $7.4B $7.1B --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $2.1B $2.1B $2.2B $2.2B --
Gross Profit $5.2B $5.3B $5.1B $4.9B --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1.1B $1.2B $1.2B $1.2B --
Other Inc / (Exp) $31.5M -$191.5M $633.5K $4.4M --
Operating Expenses $2.8B $3B $2.8B $2.8B --
Operating Income $2.5B $2.4B $2.3B $2B --
 
Net Interest Expenses $204.2M $162.6M $178.9M $178.9M --
EBT. Incl. Unusual Items $2.3B $2B $2.1B $1.9B --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $528.4M $435.4M $456.1M $415.7M --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -$472.5M -$426M -$389.7M -$336.7M --
Net Income to Common Excl Extra Items $1.3B $1.1B $1.3B $1.1B --
 
Basic EPS (Cont. Ops) $1.32 $1.15 $1.30 $1.12 --
Diluted EPS (Cont. Ops) $1.32 $1.15 $1.30 $1.12 --
Weighted Average Basic Share $3B $3B $3B $3B --
Weighted Average Diluted Share $3B $3B $3B $3B --
 
EBITDA $4.1B $3.9B $4B $3.6B --
EBIT $2.5B $2.2B $2.4B $2.1B --
 
Revenue (Reported) $7.4B $7.4B $7.4B $7.1B --
Operating Income (Reported) $2.5B $2.4B $2.3B $2B --
Operating Income (Adjusted) $2.5B $2.2B $2.4B $2.1B --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $1.3B $1.4B $2.7B $2B $1.9B
Short Term Investments $27.2M $86M $30M $59.9M $91.1M
Accounts Receivable, Net $793.2M $793.7M $595.7M $552.6M $682.7M
Inventory $42.1M $68.8M $54.5M $73.2M $63.8M
Prepaid Expenses $640.7M $725.8M $615.7M $520.6M $589.8M
Other Current Assets $14.7M $14.1M $28.1M $30.4M $28.3M
Total Current Assets $2.9B $3.3B $4.3B $3.5B $3.6B
 
Property Plant And Equipment $12.2B $12.1B $12.4B $12B $12.6B
Long-Term Investments $184M $296.6M $966M $553.8M $522.4M
Goodwill $101.6M $91.8M $76.9M $70.3M $69.6M
Other Intangibles $829.3M $852.5M $932.3M $892.4M $1B
Other Long-Term Assets $19M $25.1M $31.2M $21.8M $21.1M
Total Assets $16.9B $17.2B $19.3B $17.6B $18.3B
 
Accounts Payable $999M $1.2B $1.2B $1.2B $1.2B
Accrued Expenses $918.8M $998.6M $1.1B $988.5M $837.1M
Current Portion Of Long-Term Debt $629.7M $654.5M $678.3M $566.9M $657.7M
Current Portion Of Capital Lease Obligations $335.7M $336.4M $386.8M $305.4M $349.3M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $4.4B $4.8B $4.8B $4.5B $4.6B
 
Long-Term Debt $2.3B $2.1B $2.5B $1.7B $1.8B
Capital Leases -- -- -- -- --
Total Liabilities $8.5B $8.8B $9.2B $8B $8.3B
 
Common Stock $356.6M $346.7M $346.7M $317M $317M
Other Common Equity Adj $16M $16.5M $18.4M $36.1M $32M
Common Equity $7.2B $7.2B $8.5B $8.3B $8.7B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $1.3B $1.3B $1.6B $1.3B $1.3B
Total Equity $8.4B $8.4B $10.2B $9.5B $10B
 
Total Liabilities and Equity $16.9B $17.2B $19.3B $17.6B $18.3B
Cash and Short Terms $1.3B $1.5B $2.7B $2.1B $1.9B
Total Debt $3.6B $3.5B $3.7B $2.8B $3.1B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $1.2B $1.2B $2.1B $1.7B $1.6B
Short Term Investments $23.7M $42.8M $21.5M $100.6M $173.9M
Accounts Receivable, Net $852.3M $777.8M $626.4M $643.2M $829.6M
Inventory $68.7M $56.9M $77.9M $95.9M $59.6M
Prepaid Expenses $435.9M $451.8M $444.6M $459.5M $269.3M
Other Current Assets $18.6M $27.3M $48M $54.4M $30.9M
Total Current Assets $2.7B $2.8B $3.5B $3.3B $3.5B
 
Property Plant And Equipment $11.3B $11.9B $12B $12.5B $13.1B
Long-Term Investments $137.5M $704.6M $783.4M $566.4M $506.6M
Goodwill $92.1M $94.9M $71.9M $70.9M $70.8M
Other Intangibles $818.9M $913.6M $898M $1B $1.1B
Other Long-Term Assets $16M $28.4M $30.4M $20.4M $20.1M
Total Assets $15.6B $17B $17.8B $18B $18.8B
 
Accounts Payable $977.1M $940.1M $897.4M $873.9M $949.1M
Accrued Expenses $916.8M $923.4M $939.8M $847.9M $861.3M
Current Portion Of Long-Term Debt $456.4M $648.5M $518.9M $778.5M $1.1B
Current Portion Of Capital Lease Obligations $361.6M $406.2M $274.4M $369.8M $458.6M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $4.3B $4.7B $4.3B $4.6B $4.9B
 
Long-Term Debt $2.1B $2.4B $2B $1.7B $1.5B
Capital Leases -- -- -- -- --
Total Liabilities $7.7B $8.8B $8.2B $8.2B $8.6B
 
Common Stock $331.9M $341.8M $326.9M $321.9M $326.9M
Other Common Equity Adj $1B $1.1B $1B $996.9M $1B
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $1.1B $972.4M $1.4B $1.2B $1.2B
Total Equity $7.9B $8.2B $9.6B $9.7B $10.2B
 
Total Liabilities and Equity $15.6B $17B $17.8B $18B $18.8B
Cash and Short Terms $1.2B $1.2B $2.1B $1.8B $1.8B
Total Debt $3.2B $3.8B $3.3B $3.3B $3.3B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures $2.6B $2.2B $2.3B $2.6B $2.4B
Cash Acquisitions -$96M -- -- -- --
Cash From Investing -$2.5B -$2.4B -$2.6B -$2.6B -$2.4B
 
Dividends Paid (Ex Special Dividend) -$1.1B -$1.1B -$1.2B -$1B -$1.1B
Special Dividend Paid
Long-Term Debt Issued $1.9B $1.7B $3.2B $2.4B $2.5B
Long-Term Debt Repaid -$1.6B -$2B -$3.3B -$3.5B -$2.8B
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$675.2M -$536.4M -$921.9M -$726.4M -$645.2M
Cash From Financing -$1.6B -$1.9B -$889.4M -$2.8B -$1.7B
 
Beginning Cash (CF) $1.2B $1.3B $1.4B $2.6B $2.1B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $64.7M $159.2M $1.2B -$453.5M -$189.9M
Ending Cash (CF) $1.3B $1.4B $2.7B $2.2B $1.9B
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures $461.6M $589.5M $667.3M $399.3M --
Cash Acquisitions -$2.9M -- -- -- --
Cash From Investing -$474.4M -$623.6M -$692.1M -$386.2M --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $709.3M $359.3M $470.8M $403.7M --
Long-Term Debt Repaid -$585.4M -$805.6M -$711.7M -$1B --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$98.2M -- -- -$5M --
Cash From Financing $25.7M -$443.1M -$240.8M -$602.2M --
 
Beginning Cash (CF) $1.4B $2.7B $2.1B $1.9B --
Foreign Exchange Rate Adjustment $7.2M $1.8M -$10.2M $11.4M --
Additions / Reductions $774.2M $229.2M -$121.6M $21.5M --
Ending Cash (CF) $2.2B $2.9B $2B $1.9B --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures $2.3B $2.4B $2.4B $2.6B $2B
Cash Acquisitions -$45.6M -$2.9M $2.9M -- --
Cash From Investing -$2.3B -$3B -$2.6B -$2.6B -$2.1B
 
Dividends Paid (Ex Special Dividend) -$1B -$1.2B -$999.6M -$1.1B -$1.1B
Special Dividend Paid
Long-Term Debt Issued $1.5B $3.1B $2.7B $2.4B $2.5B
Long-Term Debt Repaid -$2.1B -$3B -$3.4B -$2.8B -$3B
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$599M -$784.5M -- -- -$480M
Cash From Financing -$2.2B -$1.8B -$1.1B -$2.2B -$2.1B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $154.4M $9.9M $985.3M -$384.1M -$73.8M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures $461.6M $589.5M $667.3M $399.3M --
Cash Acquisitions -$2.9M -- -- -- --
Cash From Investing -$474.4M -$623.6M -$692.1M -$386.2M --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $709.3M $359.3M $470.8M $403.7M --
Long-Term Debt Repaid -$585.4M -$805.6M -$711.7M -$1B --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$98.2M -- -- -$5M --
Cash From Financing $25.7M -$443.1M -$240.8M -$602.2M --
 
Beginning Cash (CF) $1.4B $2.7B $2.1B $1.9B --
Foreign Exchange Rate Adjustment $7.2M $1.8M -$10.2M $11.4M --
Additions / Reductions $774.2M $229.2M -$121.6M $21.5M --
Ending Cash (CF) $2.2B $2.9B $2B $1.9B --
 
Levered Free Cash Flow -- -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Could IBIT Go?
How High Could IBIT Go?

Recently, a surprising number of billionaire hedge fund managers have…

Is Raymond James Stock a Buy, Sell or Hold?
Is Raymond James Stock a Buy, Sell or Hold?

Raymond James Financial (NYSE:RJF) is one of America’s large financial…

Is JHX Stock a Buy Sell or Hold?
Is JHX Stock a Buy Sell or Hold?

James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
41
Is NVDA Stock a Buy?

Market Cap: $2.6T
P/E Ratio: 37x

Alerts

Buy
80
CORT alert for Apr 1

Corcept Therapeutics [CORT] is down 7.87% over the past day.

Sell
47
RGC alert for Apr 1

Regencell Bioscience Holdings [RGC] is down 0.85% over the past day.

Buy
74
COOP alert for Apr 1

Mr. Cooper Group [COOP] is up 1.51% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock